From: Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats
Groups | Treatment | Dose (kg/day, p.o.) | ELT (day 1) in sec | ELT (day 4) in sec |
---|---|---|---|---|
I | Control | 10 ml(0.5%w/w CMC) | 81.5 ± 4.5 | 20.2 ± 2.2a |
II | L-Methionine | 1.7 g | 93.8 ± 4.2 | 49.9 ± 2.4b |
III | Atorvastatin per se | 10 mg | 85.5 ± 4.1 | 22.4 ± 3.4 |
IV | Pitavastatin per se | 10 mg | 82.3 ± 4.3 | 21.3 ± 3.8 |
V | L-Methionine + Atorvastatin | 10 mg | 81.9 ± 3.9 | 27.0 ± 2.4c |
VI | L-Methionine + Pitavastatin | 10 mg | 82.5 ± 4.4 | 27.9 ± 3.6c |